Cullinan Therapeutics, Inc. CGEM

Set alert

Price alert · CGEM

All alert types
15.03 USD -0.42 -2.72%

At close · Oct 30

15.03 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
15.03 × 2
Ask
15.06 × 2
14.70 Day range 15.72
7.19 52-week range 22.95
YTD
+45.22%
1 year
+98.81%
Open
15.38
Prev close
15.45
Mkt cap
967.25M
Vol
389.42K
Avg vol
905.33K
EPS
-3.11
P/E
0.00
Div yield
0.00%
More statistics
Low
14.70
High
15.72
Forward P/E
-6.30
Beta
-0.04
Short ratio
6.17
Inst. own
112.54%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
18.28
200-d avg
15.74
1y target
34.60

MAX chart

Chart tools
Interval

Events in this range
  • Aug 7, 2025Earnings: -1.07; estimate -0.83; surprise -28.92%
  • Nov 6, 2025Earnings: -0.77; estimate -0.95; surprise 18.95%
  • Mar 10, 2026Earnings: -0.77; estimate -0.8; surprise 3.75%
  • May 7, 2026Earnings: -0.75; estimate -0.83588; surprise 10.27%
  • Aug 6, 2026Earnings: -0.81; estimate -0.79931; surprise -1.34%
  • Sep 14, 2026Rating: BTIG · Buy → Buy
  • Sep 25, 2026Rating: BTIG · Buy → Buy
  • Sep 25, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 2, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 19, 2026Rating: BTIG · Buy → Buy
  • Oct 28, 2026Rating: BTIG · Buy → Buy
  • Nov 5, 2026Earnings: —; estimate -0.84349; surprise —%
Signals (112)
NameDateAgo
SMA: BearishSep 21, 20261 month ago
SMA: BearishSep 21, 20261 month ago
MACD: Sell SignalSep 21, 20261 month ago
MACD: Buy SignalJun 22, 20264 months ago
SMA: BullishJun 15, 20264 months ago
SMA: BearishJun 1, 20265 months ago
MACD: Sell SignalJun 1, 20265 months ago
SMA: BullishMay 25, 20265 months ago
MACD: Buy SignalMay 25, 20265 months ago
SMA: BearishMay 18, 20265 months ago
MACD: Sell SignalMay 18, 20265 months ago
MACD: Buy SignalMay 11, 20265 months ago
SMA: BullishMay 4, 20266 months ago
SMA: BearishApr 20, 20266 months ago
MACD: Sell SignalApr 20, 20266 months ago
SMA: BullishMar 30, 20267 months ago
SMA: BearishMar 16, 20267 months ago
RSI: OverboughtFeb 23, 20268 months ago
SMA: BullishNov 10, 202511 months ago
SMA: BearishNov 3, 202512 months ago
SMA: BullishOct 13, 20251 year ago
SMA: BullishOct 6, 20251 year ago
MACD: Buy SignalOct 6, 20251 year ago
MACD: Sell SignalSep 22, 20251 year ago
SMA: BearishAug 25, 20251 year ago
SMA: BullishAug 18, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BullishJul 21, 20251 year ago
SMA: BearishJun 16, 20251 year ago
SMA: BullishMay 26, 20251 year ago
SMA: BearishMay 5, 20251 year ago
SMA: BullishApr 28, 20251 year ago
MACD: Buy SignalApr 21, 20251 year ago
RSI: OversoldMar 17, 20251 year ago
RSI: OversoldFeb 17, 20251 year ago
SMA: BearishSep 23, 20242 years ago
SMA: BullishSep 16, 20242 years ago
SMA: BearishSep 9, 20242 years ago
SMA: BearishSep 2, 20242 years ago
SMA: BullishAug 26, 20242 years ago
SMA: BullishAug 19, 20242 years ago
SMA: BearishJul 29, 20242 years ago
SMA: BearishJul 29, 20242 years ago
SMA: BullishJul 22, 20242 years ago
SMA: BullishJul 15, 20242 years ago
SMA: BearishJul 1, 20242 years ago
SMA: BearishJun 10, 20242 years ago
MACD: Sell SignalJun 10, 20242 years ago
SMA: BullishApr 22, 20242 years ago
MACD: Buy SignalApr 22, 20242 years ago
RSI: OverboughtApr 22, 20242 years ago
MACD: Sell SignalApr 15, 20242 years ago
SMA: BearishMar 25, 20242 years ago
RSI: OverboughtJan 29, 20242 years ago
SMA: BullishDec 25, 20232 years ago
SMA: BullishDec 18, 20232 years ago
MACD: Buy SignalDec 18, 20232 years ago
SMA: BearishNov 6, 20232 years ago
SMA: BullishOct 30, 20233 years ago
SMA: BearishSep 4, 20233 years ago
SMA: BearishSep 4, 20233 years ago
MACD: Sell SignalSep 4, 20233 years ago
SMA: BullishAug 21, 20233 years ago
SMA: BullishAug 21, 20233 years ago
MACD: Buy SignalAug 21, 20233 years ago
MACD: Sell SignalJul 31, 20233 years ago
SMA: BearishJul 17, 20233 years ago
SMA: BearishJul 17, 20233 years ago
SMA: BullishJul 10, 20233 years ago
SMA: BullishJul 10, 20233 years ago
SMA: BearishJun 26, 20233 years ago
SMA: BearishJun 26, 20233 years ago
SMA: BullishJun 5, 20233 years ago
MACD: Buy SignalMay 29, 20233 years ago
SMA: BullishMay 22, 20233 years ago
SMA: BearishApr 24, 20233 years ago
SMA: BullishApr 17, 20233 years ago
MACD: Sell SignalMar 27, 20233 years ago
SMA: BearishMar 20, 20233 years ago
SMA: BullishMar 13, 20233 years ago
SMA: BearishMar 6, 20233 years ago
SMA: BullishFeb 27, 20233 years ago
SMA: BearishFeb 20, 20233 years ago
MACD: Buy SignalJan 30, 20233 years ago
SMA: BullishJan 23, 20233 years ago
MACD: Sell SignalDec 5, 20223 years ago
SMA: BearishNov 28, 20223 years ago
SMA: BearishNov 28, 20223 years ago
SMA: BullishNov 21, 20223 years ago
SMA: BullishNov 21, 20223 years ago
SMA: BearishOct 31, 20224 years ago
SMA: BearishOct 31, 20224 years ago
SMA: BullishOct 24, 20224 years ago
SMA: BullishOct 24, 20224 years ago
SMA: BearishOct 17, 20224 years ago
SMA: BullishSep 26, 20224 years ago
SMA: BearishSep 12, 20224 years ago
SMA: BearishAug 15, 20224 years ago
SMA: BullishJun 20, 20224 years ago
SMA: BullishMay 16, 20224 years ago
SMA: BearishMar 14, 20224 years ago
SMA: BullishMar 7, 20224 years ago
SMA: BearishFeb 28, 20224 years ago
SMA: BullishFeb 14, 20224 years ago
MACD: Buy SignalFeb 14, 20224 years ago
RSI: OversoldJan 17, 20224 years ago
MACD: Sell SignalNov 15, 20214 years ago
SMA: BearishSep 13, 20215 years ago
SMA: BullishAug 2, 20215 years ago
SMA: BearishJun 14, 20215 years ago
SMA: BullishMay 31, 20215 years ago
SMA: BearishMar 22, 20215 years ago

Financial health

Altman Z-Score

9.63 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -2.8×
FY 2018: -1.7×FY 2019: -1.5×FY 2020: -25.1×FY 2021: -10.4×FY 2022: 4.3×FY 2023: -2.8×FY 2024: -3.9×FY 2025: -2.8×
FY 2018 5y median -2.8× FY 2025
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 36.1×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 1.5×
FY 2018: -1.2×FY 2019: -0.7×FY 2020: 6.5×FY 2021: 1.6×FY 2022: 0.9×FY 2023: 0.9×FY 2024: 1.1×FY 2025: 1.5×
FY 2018 5y median 1.1× FY 2025
P/FCF -3.5×
FY 2018: -1.7×FY 2019: -1.5×FY 2020: -43.7×FY 2021: -15.5×FY 2022: -3.7×FY 2023: -3.1×FY 2024: -4.5×FY 2025: -3.5×
FY 2018 5y median -3.7× FY 2025
EV/EBITDA -2.4×
FY 2018: 0.7×FY 2019: 1.5×FY 2020: -18.8×FY 2021: -9.2×FY 2022: -2.5×FY 2023: -1.7×FY 2024: -3.4×FY 2025: -2.4×
FY 2018 5y median -2.5× FY 2025
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 32.9×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -28.8%
FY 2018: -57.7%FY 2019: -68.8%FY 2020: -2.3%FY 2021: -6.4%FY 2022: -26.8%FY 2023: -31.8%FY 2024: -22.2%FY 2025: -28.8%
FY 2018 5y median -26.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -358.7%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -346.1%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -53.8%
FY 2018: 68.7%FY 2019: 49.1%FY 2020: -26.0%FY 2021: -15.4%FY 2022: 20.8%FY 2023: -33.8%FY 2024: -28.4%FY 2025: -53.8%
FY 2018 5y median -28.4% FY 2025
ROIC -58.7%
FY 2018: -43.8%FY 2019: -22.7%FY 2020: -30.1%FY 2021: -16.0%FY 2022: 19.3%FY 2023: -38.3%FY 2024: -33.2%FY 2025: -58.7%
FY 2018 5y median -33.2% FY 2025
ROA -49.0%
FY 2018: -41.0%FY 2019: -19.9%FY 2020: -24.1%FY 2021: -15.0%FY 2022: 19.8%FY 2023: -31.6%FY 2024: -26.9%FY 2025: -49.0%
FY 2018 5y median -26.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 FY 2025
Operating Income -22.7%
FY 2018: 0.0%FY 2019: -52.7%FY 2020: -170.9%FY 2021: -12.6%FY 2022: 312.9%FY 2023: -232.1%FY 2024: -3.1%FY 2025: -22.7%
FY 2018 FY 2025
EPS (diluted) -19.6%
FY 2018: 0.0%FY 2019: -10.9%FY 2020: 94.0%FY 2021: -24.4%FY 2022: 260.8%FY 2023: -255.0%FY 2024: 15.7%FY 2025: -19.6%
FY 2018 FY 2025
Free Cash Flow -21.0%
FY 2018: 0.0%FY 2019: -51.5%FY 2020: -42.4%FY 2021: -47.8%FY 2022: -190.3%FY 2023: -5.2%FY 2024: -8.0%FY 2025: -21.0%
FY 2018 FY 2025

Financial Health

Current Ratio 10.2×
FY 2018: 25.8×FY 2019: 39.7×FY 2020: 14.8×FY 2021: 25.2×FY 2022: 21.1×FY 2023: 17.1×FY 2024: 13.5×FY 2025: 10.2×
FY 2018 5y median 17.1× FY 2025
Quick Ratio 10.2×
FY 2018: 25.8×FY 2019: 39.7×FY 2020: 14.8×FY 2021: 25.2×FY 2022: 21.1×FY 2023: 17.1×FY 2024: 13.5×FY 2025: 10.2×
FY 2018 5y median 17.1× FY 2025
Debt / Equity 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2018: 2.3×FY 2019: 2.8×FY 2020: 2.8×FY 2021: 0.9×FY 2022: 1.1×FY 2023: 0.5×FY 2024: 0.5×FY 2025: 0.4×
FY 2018 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31